Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 058904/0325 | |
| Pages: | 5 |
| | Recorded: | 01/31/2022 | | |
Attorney Dkt #: | 2022-0061A |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT NAME OF THE ASSIGNEE SHOULD READ KM BIOLOGICS CO., LTD. PREVIOUSLY RECORDED AT REEL: 058778 FRAME: 0637. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17630301
|
Filing Dt:
|
01/26/2022
|
Publication #:
|
|
Pub Dt:
|
08/25/2022
| | | | |
Title:
|
TISSUE FIBROSIS INHIBITOR IN WHICH BIOCOMPATIBLE POLYMER IS USED
|
|
Assignee
|
|
|
1-6-1 OKUBO, KITA-KU, KUMAMOTO-SHI |
KUMAMOTO, JAPAN 860-8568 |
|
Correspondence name and address
|
|
WENDEROTH, LIND & PONACK, L.L.P.
|
|
1025 CONNECTICUT AVENUE N.W.
|
|
SUITE 500
|
|
WASHINGTON, DC 20036
|
Search Results as of:
05/04/2024 03:48 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|